Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$37.88 - $43.77 $1,515 - $1,750
40 Added 0.74%
5,415 $231,000
Q4 2023

Feb 06, 2024

SELL
$31.71 - $38.95 $16,520 - $20,292
-521 Reduced 8.84%
5,375 $207,000
Q3 2023

Nov 13, 2023

BUY
$37.32 - $49.29 $4,702 - $6,210
126 Added 2.18%
5,896 $222,000
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $1,519 - $1,811
38 Added 0.66%
5,770 $262,000
Q1 2023

May 08, 2023

SELL
$37.58 - $52.57 $6,087 - $8,516
-162 Reduced 2.75%
5,732 $232,000
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $1,093 - $1,269
22 Added 0.37%
5,894 $300,000
Q3 2022

Nov 10, 2022

SELL
$53.86 - $66.8 $215 - $267
-4 Reduced 0.07%
5,872 $316,000
Q2 2022

Aug 05, 2022

BUY
$63.83 - $80.0 $2,425 - $3,040
38 Added 0.65%
5,876 $377,000
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $1,613 - $1,878
-21 Reduced 0.36%
5,838 $453,000
Q4 2021

Feb 15, 2022

BUY
$74.57 - $87.19 $4,697 - $5,492
63 Added 1.09%
5,859 $503,000
Q3 2021

Nov 15, 2021

SELL
$73.77 - $83.61 $1,327 - $1,504
-18 Reduced 0.31%
5,796 $466,000
Q2 2021

Aug 12, 2021

BUY
$80.5 - $88.01 $1,449 - $1,584
18 Added 0.31%
5,814 $468,000
Q1 2021

May 13, 2021

BUY
$76.38 - $86.03 $47,202 - $53,166
618 Added 11.94%
5,796 $489,000
Q4 2020

Feb 10, 2021

BUY
$75.39 - $82.36 $7,312 - $7,988
97 Added 1.91%
5,178 $415,000
Q3 2020

Nov 12, 2020

BUY
$78.33 - $90.73 $2,036 - $2,358
26 Added 0.51%
5,081 $409,000
Q2 2020

Aug 11, 2020

SELL
$78.66 - $94.14 $3,303 - $3,953
-42 Reduced 0.82%
5,055 $435,000
Q1 2020

May 12, 2020

BUY
$71.57 - $93.3 $3,435 - $4,478
48 Added 0.95%
5,097 $414,000
Q4 2019

Feb 10, 2020

BUY
$76.7 - $88.45 $387,258 - $446,584
5,049 New
5,049 $422,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Stokes Family Office, LLC Portfolio

Follow Stokes Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.